Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions – Fifth Meeting
National Academies of Sciences 2101 Constitution Ave NW, Washington, DC, United StatesIn response to a Congressional request, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine is conducting a study on processes for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States and the European Union. This is the fifth meeting of the committee of